Abbott Laboratories (ABT) Stock: $109.93, Down 3.23% Nov 6
Abbott Laboratories (ABT) Stock: $109.93, Down 3.23% Nov 6 JournalArta
Covered in this story
Analyst targets on Abbott Laboratories
- BTIG: $103 → $125 by Oct 2027 · Buy via Investing.com
- Mizuho: $103 → $115 by Oct 2027 · Neutral via Investing.com
- StoneX: $103 → $120 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ABT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Abbott Laboratories →Dalsna Finance is currently tracking 42 stories mentioning Abbott Laboratories, the earliest published 6 May 2017.
Summary aggregated from JournalArta's public RSS feed. The full reporting belongs to JournalArta — please read it on their site.